Should we use apoB for risk assessment and as a target for treatment?

J Clin Lipidol. 2010 May-Jun;4(3):144-51. doi: 10.1016/j.jacl.2010.03.004. Epub 2010 Mar 16.
No abstract available

MeSH terms

  • Anti-Infective Agents / therapeutic use
  • Apolipoproteins B / blood*
  • Apolipoproteins B / standards
  • Atherosclerosis / blood*
  • Atherosclerosis / drug therapy
  • Atherosclerosis / etiology*
  • Biomarkers / blood
  • Blood Chemical Analysis / standards
  • Cholesterol, LDL / blood
  • Clinical Trials as Topic
  • Humans
  • Lipids / blood
  • Lipoproteins / blood
  • Risk Factors

Substances

  • Anti-Infective Agents
  • Apolipoproteins B
  • Biomarkers
  • Cholesterol, LDL
  • Lipids
  • Lipoproteins